FREQUENCY OF ELEVATED HEPATOCELLULAR CARCINOMA (HCC) BIOMARKERS (AFP, AFP-L3, AND DCP) IN PATIENTS WITH CHRONIC HEPATITIS C (CHC)AND ADVANCED FIBROSIS WITH AND WITHOUT HCC

被引：0
|
作者：
Sterling, Richard K. [1 ]
Wright, Elizabeth C. [2 ]
Morgan, Timothy R. [3 ]
Seeff, Leonard B. [2 ]
Hoefs, John C. [4 ]
Di Bisceglie, Adrian M. [5 ]
Dienstag, Jules L. [6 ]
Lok, Anna S. [7 ]
机构：
[1] Virginia Commonwealth Univ, Div Gastroenterol & Hepatol, Richmond, VA USA
[2] NIDDK, NIH, Bethesda, MD USA
[3] VA Long Beach Healthcare Syst, Long Beach, CA USA
[4] Univ Calif Irvine, Ann Arbor, MI USA
[5] St Louis Univ, St Louis, MO 63103 USA
[6] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[7] Univ Michagan, Ann Arbor, MI USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
18
引用
收藏
页码：328A / 328A
页数：1
相关论文
共 50 条
  • [21] Des-γ-carboxyprothrombin, α-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma
    Durazo, Francisco A.
    Blatt, Lawrence M.
    Corey, William G.
    Lin, Jiing-Huey
    Han, Steven
    Saab, Sammy
    Busuttil, Ronald W.
    Tong, Myron J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (10) : 1541 - 1548
  • [22] Utility of four tumor markers, alone and in combination, for detection of hepatocellular carcinoma: AFP, AFP-L3, DCP, and Cystatin
    Li, H.
    Sferruzza, A.
    Qu, K. Z.
    Afdhal, N. H.
    Lai, M.
    Radcliff, J. S.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
    Kentaroh Yamamoto
    Hiroshi Imamura
    Yutaka Matsuyama
    Yukio Kume
    Hitoshi Ikeda
    Gary L. Norman
    Zakera Shums
    Taku Aoki
    Kiyoshi Hasegawa
    Yoshifumi Beck
    Yasuhiko Sugawara
    Norihiro Kokudo
    Journal of Gastroenterology, 2010, 45 : 1272 - 1282
  • [24] Chinese expert consensus statement on the clinical application of AFP/AFP-L3%/DCP using GALAD and GALAD-like algorithm in HCC
    Huang, Chenjun
    Xiao, Xiao
    Zhou, Lin
    Chen, Fuxiang
    Wang, Jianyi
    Hu, Xiaobo
    Gao, Chunfang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (23-24)
  • [25] AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
    Yamamoto, Kentaroh
    Imamura, Hiroshi
    Matsuyama, Yutaka
    Kume, Yukio
    Ikeda, Hitoshi
    Norman, Gary L.
    Shums, Zakera
    Aoki, Taku
    Hasegawa, Kiyoshi
    Beck, Yoshifumi
    Sugawara, Yasuhiko
    Kokudo, Norihiro
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (12) : 1272 - 1282
  • [26] A COMBINATION OF AFP-L3 AND DCP PREDICTS HCC RECURRENCE AFTER LIVER TRANSPLANT: RESULTS OF A PROSPECTIVE STUDY
    Norman, Joshua Scott
    Kotwani, Prashant
    Yao, Francis
    Mehta, Neil
    HEPATOLOGY, 2021, 74 : 868A - 869A
  • [27] THE PERFORMANCE OF TRIPLE BIOMARKERS (AFP, AFP-3, DCP) FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA (HCC). A PROSPECTIVE COHORT PHASE 3 BIOMARKER STUDY IN THE UNITED STATES
    El-Serag, Hashem B.
    Tayob, Nabihah
    Kanwal, Fasiha
    Alsarraj, Abeer
    Hernaez, Ruben
    GASTROENTEROLOGY, 2019, 156 (06) : S1309 - S1310
  • [28] The performance of biomarkers for hepatocellular carcinoma varies according to risk factor stratification and etiology of liver disease: A comparison of AFP-L3, total AFP and DCP
    Volk, Michael L.
    Su, Grace L.
    Lok, Anna S.
    Marrero, Jorge A.
    GASTROENTEROLOGY, 2006, 130 (04) : A774 - A774
  • [29] Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
    Llovet, J.
    Kudo, M.
    Kang, Y-K.
    Yen, C-J.
    Finn, R. S.
    Galle, P. R.
    Assenat, E.
    Motomura, K.
    Okusaka, T.
    Berg, T.
    Hsu, C-H.
    Ikeda, M.
    Hsu, Y.
    Liang, K.
    Widau, R.
    Schelman, W.
    O'Brien, L.
    Gao, L.
    Zhu, A. X.
    ANNALS OF ONCOLOGY, 2019, 30 : 293 - +
  • [30] A MODIFIED RETREAT SCORE INCORPORATING AFP-L3 AND DCP BIOMARKERS IMPROVES POST-LIVER TRANSPLANT HCC RECURRENCE RISK PROGNOSTICATION
    Norman, Joshua Scott
    Kotwani, Prashant
    Shui, Amy
    Dodge, Jennifer L.
    Yao, Francis
    Mehta, Neil
    HEPATOLOGY, 2022, 76 : S58 - S59
12345